The ISPOR Medical Device and Diagnostics Special Interest Group (MDD-SIG) is conducting a key project to characterize the usage of Health Technology Assessment (HTA) in procurement decisions. The goal of this forum is to discuss methods and initial results, and to engage the ISPOR community to inform and prioritize next steps. HTA is used to inform decision-making on the coverage and use of medical device and diagnostic technologies at the centralized, macroeconomic level and offers the potential of robust methods to help inform micro-level procurement decisions. Such use could reduce variation in access to these technologies; however, the nature of this use is not well characterized. Initial findings (predominantly from high-income countries) show that decision makers made their recommendations parallel to HTA by considering clinical data, cost-effectiveness, and safety; only a minority are based on HTA summaries and conclusions. There is little publication evidence of the generalizable link between HTA and procurement. Planned next steps involve a survey of relevant HTA and procurement stakeholders. This forum will elicit feedback on the most up-to-date version of that survey; attendees will have the opportunity to provide feedback and suggest prioritized next steps via ranking, polls, and open discussion. Discussion in this forum will include: mechanisms to increase the participation of the survey and finalize pertinent survey questions, the relative importance of different aspects of HTA in procurement decision-making, the costs and benefits of potentially duplicative assessments at the macro and micro levels, the role of the grey literature, and the role of ISPOR and its SIGs to better connect the HTA and procurement communities. The concluding period will allow for wrap up, questions, and review next steps. We welcome forum participation from MDD-SIG members, HTA professionals, payers, and anyone playing a role within or interested in medical technology procurement.